Published by Benjamin Chiou on 23rd February 2026
(Sharecast News) - US pharma group Merck & Co is set to spin off its oncology operations in an effort to keep its wider healthcare businesses immune from a forthcoming patent cliff for its blockbuster Keytruda drug.
URL: http://www.digitallook.com/dl/news/story/35715872/...